Back to top

rating-upgrade: Archive

Zacks Equity Research

Moody's (MCO) Upgraded to Buy: What Does It Mean for the Stock?

Moody's (MCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MCONegative Net Change

Zacks Equity Research

Mercantile Bank (MBWM) Upgraded to Strong Buy: Here's Why

Mercantile Bank (MBWM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MBWMNegative Net Change

Zacks Equity Research

Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know

Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NVSTPositive Net Change

Zacks Equity Research

All You Need to Know About Farmers National (FMNB) Rating Upgrade to Buy

Farmers National (FMNB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FMNBPositive Net Change

Zacks Equity Research

Gildan (GIL) Upgraded to Buy: What Does It Mean for the Stock?

Gildan (GIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GILPositive Net Change

Zacks Equity Research

All You Need to Know About Mobileye (MBLY) Rating Upgrade to Buy

Mobileye (MBLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MBLYNegative Net Change

Zacks Equity Research

Crown (CCK) Upgraded to Buy: Here's Why

Crown (CCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CCKNegative Net Change

Zacks Equity Research

Mineralys Therapeutics, Inc. (MLYS) Upgraded to Buy: Here's Why

Mineralys Therapeutics, Inc. (MLYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MLYSPositive Net Change

Zacks Equity Research

Synovus (SNV) Upgraded to Buy: What Does It Mean for the Stock?

Synovus (SNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SNVNegative Net Change

Zacks Equity Research

What Makes Centuri (CTRI) a New Buy Stock

Centuri (CTRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CTRIPositive Net Change

Zacks Equity Research

USANA Health (USNA) Upgraded to Buy: Here's Why

USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

USNANegative Net Change

Zacks Equity Research

All You Need to Know About Grupo Financiero Banorte (GBOOY) Rating Upgrade to Buy

Grupo Financiero Banorte (GBOOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GBOOYNegative Net Change

Zacks Equity Research

Bar Harbor (BHB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Bar Harbor (BHB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BHBPositive Net Change

Zacks Equity Research

All You Need to Know About Southern First (SFST) Rating Upgrade to Strong Buy

Southern First (SFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SFSTNegative Net Change

Zacks Equity Research

Merck KGaA (MKKGY) Upgraded to Strong Buy: Here's Why

Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MKKGYNegative Net Change

Zacks Equity Research

YmAbs Therapeutics (YMAB) Upgraded to Buy: Here's What You Should Know

YmAbs Therapeutics (YMAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

YMABNegative Net Change

Zacks Equity Research

Barrick Mining (B) Upgraded to Strong Buy: Here's What You Should Know

Barrick Mining (B) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BPositive Net Change

Zacks Equity Research

What Makes Acushnet (GOLF) a New Strong Buy Stock

Acushnet (GOLF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

GOLFPositive Net Change

Zacks Equity Research

All You Need to Know About Charles Schwab (SCHW) Rating Upgrade to Strong Buy

Charles Schwab (SCHW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SCHWPositive Net Change

Zacks Equity Research

National Australia Bank (NABZY) Upgraded to Buy: Here's Why

National Australia Bank (NABZY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NABZYNegative Net Change

Zacks Equity Research

ServisFirst (SFBS) Upgraded to Buy: Here's What You Should Know

ServisFirst (SFBS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SFBSNegative Net Change

Zacks Equity Research

Eldorado Gold (EGO) Upgraded to Buy: Here's What You Should Know

Eldorado Gold (EGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

EGOPositive Net Change

Zacks Equity Research

What Makes Amphastar (AMPH) a New Buy Stock

Amphastar (AMPH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AMPHNegative Net Change

Zacks Equity Research

KBC Group (KBCSY) Upgraded to Strong Buy: Here's Why

KBC Group (KBCSY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

KBCSYNegative Net Change

Zacks Equity Research

American Healthcare REIT (AHR) Upgraded to Buy: What Does It Mean for the Stock?

American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AHRNegative Net Change